A Case of C3 Glomerulopathy (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0715; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Patient was started on steroids, increased MMF dose, and planned to be started on iptacopan therapy pending insurance approval...Then, upon further investigation and workup, the markedly low C3 raised suspicion for C3G, that prompted diagnosis and initiation of appropriate therapy. This case highlights the importance of early diagnosis and initiation of treatment in hopes to reduce glomerular damage, as a quarter of patients go on to develop end stage kidney disease."
Clinical • Cardiovascular • Chronic Kidney Disease • Complement-mediated Rare Disorders • Diabetes • Diabetic Nephropathy • Glomerulonephritis • Hematological Malignancies • Hypertension • Infectious Disease • Lupus Nephritis • Metabolic Disorders • Monoclonal Gammopathy • Multiple Myeloma • Nephrology • Renal Disease
|
|
Rosemary Kallarackel; Anndrea Distor; Hadiah Kedwaii; Nathan R. Fletcher; Goutham Kondapi
|